Just the Facts:

Five (5) products, Seven (7) very realistic indications:

Lympro Alzheimer's Blood Test
NuroPro
Eltoprazine LID
Eltoprazine ADHD
ESS-W
MANF RP (US and Europe)
MANF CRVO

Many more potential indications (Ischemic Heart Disease, Diabetes, Wolframs, Parkinson's, Ototoxicity, Alzheimer's)

New diagnostic acquisition in the short-term

Discovery Platform (Phenoguard)

Two (2) Orphan Drug Designations (one more expected in about 30-45 days).

Commercial Diagnostic about to secure revenue stream with therapeutics in various stages of clinical development.

Human Resource infrastructure in place to drive development and support an Uplist

2015 is going to be interesting...